Rachel Lipscomb, APRN
Nurse Practitioner · Florence, KYNPI 1811657836
Payments from drug & device makers
Across 252 payments — averaging $19.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$405
- Vanda Pharmaceuticals Inc.$350
- Lilly USA, LLC$335
- Axsome Therapeutics, Inc.$304
- Pfizer$261
- plus $2K from 26 others
What the payments were for
- Food & beverage$4,820100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 54 | $1,077 |
| Novo Nordisk | 20 | $405 |
| Vanda Pharmaceuticals Inc. | 11 | $350 |
| Lilly USA, LLC | 28 | $335 |
| Axsome Therapeutics, Inc. | 10 | $304 |
| Pfizer | 16 | $261 |
| Otsuka America Pharmaceutical, Inc. | 13 | $244 |
| Boehringer Ingelheim | 13 | $223 |
| Exact Sciences | 9 | $197 |
| Sumitomo Pharma America, Inc. | 11 | $185 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $172 |
| Amgen | 9 | $167 |
| Astellas Pharma US Inc | 8 | $166 |
| Teva Pharmaceuticals USA, Inc. | 5 | $115 |
| AstraZeneca | 4 | $77 |
| Bayer | 4 | $64 |
| Idorsia Pharmaceuticals US Inc | 4 | $60 |
| GSK | 4 | $58 |
| Shield Therapeutics Inc | 3 | $54 |
| Lundbeck LLC | 2 | $43 |
| Almatica Pharma LLC | 2 | $40 |
| Sunovion Pharmaceuticals Inc. | 2 | $32 |
| Merck | 2 | $30 |
| Dexcom, Inc. | 1 | $29 |
| Inspire Medical Systems, Inc. | 1 | $22 |
| Sanofi Pasteur Inc. | 1 | $21 |
| Avanir Pharmaceuticals, Inc. | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| Endogastric Solutions, Inc | 1 | $13 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
| Currax Pharmaceuticals LLC | 1 | $12 |
How this compares
$4,820 in reported general payments places this provider in the 90th percentile of 1,918 nurse practitioner providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 29 | $46,126 |
| OzempicSemaglutide | 31 | $43,775 |
| GemtesaVibegron | 49 | $28,125 |
| EliquisApixaban | 31 | $25,215 |
| JardianceEmpagliflozin | 20 | $24,161 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 31 | $24,005 |
| JanuviaSitagliptin Phosphate | 18 | $16,757 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 13 | $7,990 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 15 | $7,816 |
| FarxigaDapagliflozin Propanediol | 12 | $7,771 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 111 | $3,600 |
| Dexlansoprazole DrDexlansoprazole | 13 | $3,266 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $2,302 |
| Levothyroxine Sodium | 145 | $1,291 |
| Omeprazole | 137 | $1,159 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $335 | $46,12629 claims |
| Novo NordiskOzempic | $405 | $43,77531 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $58 | $31,99544 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $185 | $28,12549 claims |
| PfizerEliquis | $261 | $25,21531 claims |
| Boehringer IngelheimJardiance | $223 | $24,16120 claims |
| MerckJanuvia | $30 | $16,75718 claims |
| AstraZenecaFarxiga | $77 | $7,77112 claims |
| Almatica Pharma LLCSertraline Hcl | $40 | $40769 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,918 nurse practitioner providers in Kentucky.
Other nurse practitioner in Florence
- Dorothy BakerFlorence$13K
- Joshua BlancherFlorence$12K
- Rachael BradfordLexington$447K
- Tara MuddLouisville$243K
- Lee HaasLouisville$95K
- Ashley KnableLouisville$86K
- Christina BenningerLouisville$81K
- Courtney BowlingCampbellsville$47K
- Rebecca BraunerLouisville$40K
- Scott SeitzWinchester$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.